A detailed history of Fox Run Management, L.L.C. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 41,531 shares of ARDX stock, worth $228,420. This represents 0.04% of its overall portfolio holdings.

Number of Shares
41,531
Previous 13,207 214.46%
Holding current value
$228,420
Previous $90,000 137.78%
% of portfolio
0.04%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$4.49 - $6.85 $127,174 - $194,019
28,324 Added 214.46%
41,531 $214,000
Q3 2024

Nov 12, 2024

BUY
$5.28 - $7.57 $69,732 - $99,976
13,207 New
13,207 $90,000
Q1 2024

May 13, 2024

BUY
$6.05 - $9.74 $139,652 - $224,828
23,083 New
23,083 $168,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $850M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.